XTNT Xtant Medical Holdings Inc

Xtant Medical Holdings Inc develops, manufactures & markets biologics products to domestic and international markets. Its products are used in treatment of spinal disease, tissue grafts for orthopedic disorders and foot and ankle surgeries.

$0.70  -0.03 (-4.53%)
As of 12/03/2021 15:59:51 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  03/07/2011
Outstanding shares:  86,707,286
Average volume:  108,192
Market cap:   $63,911,941
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    98420P308
ISIN:        US98420P3082
Valuation   (See tab for details)
PE ratio:   -18.65
PB ratio:   1.87
PS ratio:   1.16
Return on equity:   -7.86%
Net income %:   -4.64%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy